AU1570199A - Methods of lyophilizing solutions - Google Patents

Methods of lyophilizing solutions

Info

Publication number
AU1570199A
AU1570199A AU15701/99A AU1570199A AU1570199A AU 1570199 A AU1570199 A AU 1570199A AU 15701/99 A AU15701/99 A AU 15701/99A AU 1570199 A AU1570199 A AU 1570199A AU 1570199 A AU1570199 A AU 1570199A
Authority
AU
Australia
Prior art keywords
methods
lyophilizing
solutions
lyophilizing solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15701/99A
Inventor
Anthony Auffret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1570199A publication Critical patent/AU1570199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
AU15701/99A 1997-12-13 1998-12-14 Methods of lyophilizing solutions Abandoned AU1570199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9726343 1997-12-13
GBGB9726343.8A GB9726343D0 (en) 1997-12-13 1997-12-13 The use of excipients to accelerate freeze-drying
PCT/GB1998/003747 WO1999030688A1 (en) 1997-12-13 1998-12-14 Methods of lyophilizing solutions

Publications (1)

Publication Number Publication Date
AU1570199A true AU1570199A (en) 1999-07-05

Family

ID=10823551

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15701/99A Abandoned AU1570199A (en) 1997-12-13 1998-12-14 Methods of lyophilizing solutions

Country Status (3)

Country Link
AU (1) AU1570199A (en)
GB (1) GB9726343D0 (en)
WO (1) WO1999030688A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200591B1 (en) * 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
DE19834507A1 (en) * 1998-07-31 2000-02-03 Hexal Ag Pharmaceutical, water-soluble tablet formulation for the use of sildenafil
DE19834506A1 (en) * 1998-07-31 2000-02-03 Hexal Ag Transmucosal therapeutic system for the use of sildenafil
DE602005002742T2 (en) * 2004-04-22 2008-01-24 Pfizer Products Inc., Groton METHOD FOR STABILIZING UNLOCATED CEFOVECIN SODIUM SALT
FR2881139A1 (en) * 2005-01-26 2006-07-28 Agronomique Inst Nat Rech Liquid for lyophilization of proteins, useful for stabilizing pharmaceuticals or analytical proteins, comprises a filler, stabilizer, buffer and optionally nonionic surfactant
US8158152B2 (en) 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
EP2093225A1 (en) * 2007-05-01 2009-08-26 Plus Chemicals B.V. Process for preparing crystalline eletriptan hydrobromide form ß
CN109984321B (en) * 2019-03-27 2022-08-16 齐鲁工业大学 Low-energy-consumption preparation method of high-viscosity Chinese yam powder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981676A (en) * 1970-03-03 1976-09-21 L'oreal Lyophilized dyes and the use thereof to color keratinic fibers
JPH03297384A (en) * 1990-04-13 1991-12-27 Taunzu:Kk Stabilized composition of urea amidolyase
CA2128527A1 (en) * 1992-01-21 1993-07-22 Raymond P. Goodrich, Jr. Method of freezing cells and cell-like materials
US5302401A (en) * 1992-12-09 1994-04-12 Sterling Winthrop Inc. Method to reduce particle size growth during lyophilization
US5561121A (en) * 1993-11-09 1996-10-01 American Cyanamid Company Stable lyophilized thiotepa composition
GB9508691D0 (en) * 1995-04-28 1995-06-14 Pafra Ltd Stable compositions
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability

Also Published As

Publication number Publication date
WO1999030688A1 (en) 1999-06-24
GB9726343D0 (en) 1998-02-11

Similar Documents

Publication Publication Date Title
AU9790198A (en) Compounds and methods
AU8921698A (en) Follistatin-3
AU9414098A (en) Ascorbyl-phosphoryl-cholesterol
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU9513298A (en) Fluoranthenopyrans
AU5272198A (en) EMP-charge-eliminator
AU5203698A (en) Fluid-treatment assemblies
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU6303898A (en) Component of bromelain
AU8109998A (en) Waveguide
AU9367198A (en) Enzymatic modification
AU4117497A (en) Micropolarimeter
AU6998698A (en) Dioxacycloalkan-8-one
AU1570199A (en) Methods of lyophilizing solutions
AU6185898A (en) Clavaspirins
AU6525998A (en) Improved metallo-endopeptidases
AU7761998A (en) Korrosionsschutzanstrichstoff
AU8214598A (en) 3-benzylpiperidine
AU1208799A (en) Recovery of gamma-pyrones
AU8271998A (en) Methods of disease detection
AU8102498A (en) Preparation of diaryl-benzopyrans
AU5386498A (en) Enhancement phalloplasty
AUPO852797A0 (en) Enhancement phalloplasty
AU5391798A (en) Thiamacrolides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase